Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02276040 · ClinicalTrials.gov registry record
Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty
A clinical trial, sponsored by OrthoCarolina Research Institute.
- Completed
- Registry status
- 26
- Enrollment target
NCT02276040: Completed study, sponsored by OrthoCarolina Research Institute.
NCT02276040 is a clinical trial that has completed, run by OrthoCarolina Research Institute. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02276040 has completed, sponsored by OrthoCarolina Research Institute.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to quantify the total blood serum levels of bupivacaine in OrthoPAT® collected blood 2 hours and 5 hours postoperatively. Hypothesis: Filtered blood from the OrthoPAT® autotransfusion system contains low or undetectable levels of bupivacaine hydrochloride (HCL). Reinfusion of collected blood from the OrthoPAT® device when used in conjunction with periarticular bupivicaine injections will not pose a bupivocaine toxicity risk to patients undergoing a total joint arthroplasty.
Primary Outcome
Bupivocaine levels measured in the blood that is collected in a surgical drain post surgery. Blood samples will be tested for change in serum bupivicaine levels from baseline.
Interventions
- DRUG periarticular bupivicaine and liposomal bupivicaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-06-30 |
What the finished NCT02276040 record still lists
NCT02276040 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which periarticular bupivicaine and liposomal bupivicaine is the first listed.
NCT02276040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02276040 about?
NCT02276040 is a clinical study titled "Serum Levels of Bupivacaine in Autotransfusion Drains Following Total Joint Arthroplasty". The purpose of this study is to quantify the total blood serum levels of bupivacaine in OrthoPAT® collected blood 2 hours and 5 hours postoperatively. Hypothesis: Filtered blood from the OrthoPAT® autotransfusion system contains low or undetectable levels of bupivacaine hydrochloride (HCL). Reinfus...
What is the current status of trial NCT02276040?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2014-10. Estimated completion is 2017-06-30.
What interventions are being tested in trial NCT02276040?
The interventions under investigation include: periarticular bupivicaine and liposomal bupivicaine (DRUG).
Who is sponsoring clinical trial NCT02276040?
This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia